CIK: 0001825034 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $888,536 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 917,141 | $435,926 | 49.1% | $466.71 | — | TR UNIT | 78462F103 |
| GLD | SPDR GOLD TR | 1,390,000 | $265,726 | 29.9% | $178.82 | — | GOLD SHS | 78463V107 |
| INDA | ISHARES TR | 2,425,144 | $118,371 | 13.3% | $42.12 | — | MSCI INDIA ETF | 46429B598 |
| — | RAPT THERAPEUTICS INC | 657,899 | $16,349 | 1.8% | $19.12 | — | COM | 75382E109 |
| ALEC | ALECTOR INC | 1,307,858 | $10,437 | 1.2% | $10.94 | -45.8% | COM | 014442107 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,573,761 | $10,151 | 1.1% | $16.74 | -74.2% | COM | 344174107 |
| — | 23ANDME HOLDING CO | 10,243,122 | $9,357 | 1.1% | $3.83 | — | CLASS A COM | 90138Q108 |
| ORIC | ORIC PHARMACEUTICALS INC | 989,410 | $9,103 | 1.0% | $23.68 | -69.5% | COM | 68622P109 |
| PMVP | PMV PHARMACEUTICALS INC | 2,627,643 | $8,146 | 0.9% | $35.52 | -92.6% | COM | 69353Y103 |
| TNYA | TENAYA THERAPEUTICS INC | 1,015,705 | $3,291 | 0.4% | $19.78 | -89.1% | COM | 87990A106 |
| — | NGM BIOPHARMACEUTICALS INC | 992,168 | $852 | 0.1% | $23.07 | — | COM | 62921N105 |
| SRZN | SURROZEN INC | 87,696 | $824 | 0.1% | $6.97 | 0.0% | COM NEW | 86889P208 |
| SRZNW | SURROZEN INC | 170,833 | $3 | 0.0% | $0.04 | — | *W EXP 08/01/203 | 86889P117 |